Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effect of PF-06743649 in lowering serum uric acid
in subjects suffering from gout following 14 days of dosing, as well as assessing safety and
tolerability.